 |
|
|
|
|
|
| Board of Directors |
|
Executive Officers |
| |
C. ROBERT HENRIKSON
Chairman of the Board, President and
Chief Executive Officer, MetLife, Inc. |
|
CURTIS H. BARNETTE
Of Counsel, Skadden, Arps, Slate,
Meagher & Flom LLP |
|
SYLVIA MATHEWS BURWELL
President, Global Development Program,
The Bill and Melinda Gates Foundation |
|
BURTON A. DOLE, JR.
Former Partner and Chief Executive
Officer, MedSouth Therapies, LLC |
|
CHERYL W. GRISÉ
Executive Vice President of Northeast
Utilities, President, Utility Group of
Northeast Utilities, and
Chief Executive Officer
of its principal operating subsidiaries |
|
JAMES R. HOUGHTON
Chairman of the Board,
Corning Incorporated |
|
R. GLENN HUBBARD, PH.D.
Dean, Graduate School of Business, Columbia University |
|
HARRY P. KAMEN
Retired Chairman of the Board and
Chief Executive Officer,
Metropolitan Life Insurance Company |
|
HELENE L. KAPLAN
Of Counsel, Skadden, Arps, Slate,
Meagher & Flom LLP |
|
JOHN M. KEANE
General, United States Army (Retired)
Co-Founder and Senior Managing
Director, Keane Advisors, LLC |
|
JAMES M. KILTS
Founding Partner,
Centerview Partners Management, LLC |
|
CHARLES M. LEIGHTON
Executive Director, US SAILING |
|
HUGH B. PRICE
Senior Fellow, The Brookings Institution |
|
DAVID SATCHER, M.D., PH.D.
Former Surgeon General, United States |
|
KENTON J. SICCHITANO
Retired Global Managing Partner,
PricewaterhouseCoopers LLP |
|
WILLIAM C. STEERE, JR.
(Lead Director)
Retired Chairman of the Board and
Chief Executive Officer, Pfizer Inc.
Executive Officers |
|
|
|
C. ROBERT HENRIKSON
Chairman of the Board,
President and
Chief Executive Officer |
|
STEVEN A. KANDARIAN
Executive Vice President and
Chief Investment Officer |
|
JAMES L. LIPSCOMB
Executive Vice President and
General Counsel |
|
WILLIAM J. MULLANEY
President, Institutional Business |
|
CATHERINE A. REIN
Senior Executive Vice President
and Chief Administrative Officer |
|
WILLIAM J. TOPPETA
President, International |
|
LISA M. WEBER
President, Individual Business |
|
WILLIAM J. WHEELER
Executive Vice President and
Chief Financial Officer |
|
|
| This Annual Review contains statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to trends in the operations and financial results and the business and the products of the company and its subsidiaries, as well as other statements including words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend” and other similar expressions. Forward-looking statements are made based upon management’s current expectations and beliefs concerning future developments and their potential effects on the company. Such forward-looking statements are not guarantees of future performance. |
|
| Actual results may differ materially from those included in the forward-looking statements as a result of risks and uncertainties including, but not limited to, the following: (i) changes in general economic conditions, including the performance of financial markets and interest rates; (ii) heightened competition, including with respect to pricing, entry of new competitors, the development of new products by new and existing competitors and for personnel; (iii) investment losses and defaults; (iv) unanticipated changes in industry trends; (v) catastrophe losses; (vi) ineffectiveness of risk management policies and procedures; (vii) changes in accounting standards, practices and/or policies; (viii) changes in assumptions related to deferred policy acquisition costs, value of business acquired or goodwill; (ix) discrepancies between actual claims experience and assumptions used in setting prices for the company’s products and establishing the liabilities for the company’s obligations for future policy benefits and claims; (x) discrepancies between actual experience and assumptions used in establishing liabilities related to other contingencies or obligations; (xi) adverse results or other consequences from litigation, arbitration or regulatory investigations; (xii) downgrades in the company’s and its affiliates’ claims paying ability, financial strength or credit ratings; (xiii) regulatory, legislative or tax changes that may affect the cost of, or demand for, the company’s products or services; (xiv) MetLife, Inc.’s primary reliance, as a holding company, on dividends from its subsidiaries to meet debt payment obligations and the applicable regulatory restrictions on the ability of the subsidiaries to pay such dividends; (xv) deterioration in the experience of the “closed block” established in connection with the reorganization of Metropolitan Life Insurance Company; (xvi) economic, political, currency and other risks relating to the company’s international operations; (xvii) the effects of business disruption or economic contraction due to terrorism or other hostilities; (xviii) the company’s ability to identify and consummate on successful terms any future acquisitions, and to successfully integrate acquired businesses with minimal disruption; and (xix) other risks and uncertainties described from time to time in MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission. The company specifically disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. |
|
|
|
|
|
|
